BioStem wins US patent for sterile human placental allografts, methods of making them

Bitget2026/10/01 11:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

BioStem Technologies reported a newly issued U.S. patent covering sterile human placental allografts and related manufacturing methods.
Three additional U.S. patent applications received notices of allowance spanning placental allografts, micronized umbilical cord combinations for wound care, and joint-use extracts.
A Mexican patent application also received a notice of allowance tied to the placental allograft technology.
The update expands BioStem’s patent estate across wound care, surgical use, and joint applications.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biostem Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610010700PRIMZONEFULLFEED9837763) on October 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

BioStem wins US patent for sterile human placental allografts, methods of making them

You may also like

Crypto prices